Compounds > indazoles
Page last updated: 2024-08-21

indazoles and Sarcoma, Ewing

indazoles has been researched along with Sarcoma, Ewing in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (85.71)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Beck, JF; Becker, S; Kerschner-Morales, SL; Kühne, M; Sonnemann, J1
Iida, S; Joh, T; Kanamori, T; Kataoka, H; Kinoshita, S; Komatsu, H; Kondo, M; Kuroda, J; Mori, Y; Takemoto, M1
Bando, M; Endo, S; Hagiwara, K; Kurosaki, A; Mato, N; Niki, T; Onuki, T; Sakamoto, N; Takigami, A; Tetsuka, K; Yamasawa, H1
Minami, T; Nozawa, M; Shimizu, N; Uemura, H; Yamamoto, Y; Yoshimura, K1
Alcindor, T1
Denny, CT; Federman, N; Glaser, KB; Ikeda, AK; Judelson, DR; Landaw, EM; Sakamoto, KM1
Houghton, PJ; Keir, ST; Kurmasheva, RT; Morton, CL; Smith, MA; Wu, J1

Other Studies

7 other study(ies) available for indazoles and Sarcoma, Ewing

ArticleYear
Anticancer effects of the PLK4 inhibitors CFI-400945 and centrinone in Ewing's sarcoma cells.
    Journal of cancer research and clinical oncology, 2020, Volume: 146, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Survival; Humans; Indazoles; Indoles; Membrane Potential, Mitochondrial; Protein Serine-Threonine Kinases; Pyrimidines; Sarcoma, Ewing; Sulfones

2020
The Successful Treatment of Metastatic Extraosseous Ewing Sarcoma with Pazopanib.
    Internal medicine (Tokyo, Japan), 2018, Sep-15, Volume: 57, Issue:18

    Topics: Adolescent; Angiogenesis Inhibitors; Antineoplastic Agents; Bone Neoplasms; Female; Humans; Indazoles; Lung Neoplasms; Pyrimidines; Sarcoma, Ewing; Sulfonamides; Vaginal Neoplasms

2018
Pazopanib Confers a Progression-free Survival in a Patient with Ewing's Sarcoma/Primitive Neuroectodermal Tumor of the Lung.
    Internal medicine (Tokyo, Japan), 2019, May-01, Volume: 58, Issue:9

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Fatal Outcome; Humans; Indazoles; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neuroectodermal Tumors, Primitive; Pneumonectomy; Progression-Free Survival; Pyrimidines; Sarcoma, Ewing; Sulfonamides; Treatment Outcome

2019
Pazopanib for recurrent extraosseous Ewing's sarcoma of the retroperitoneum.
    International journal of urology : official journal of the Japanese Urological Association, 2014, Volume: 21, Issue:11

    Topics: Fatal Outcome; Humans; Indazoles; Male; Middle Aged; Neoplasm Recurrence, Local; Pyrimidines; Retroperitoneal Neoplasms; Sarcoma, Ewing; Sulfonamides

2014
Response of refractory Ewing sarcoma to pazopanib.
    Acta oncologica (Stockholm, Sweden), 2015, Volume: 54, Issue:7

    Topics: Angiogenesis Inhibitors; Bone Neoplasms; Female; Humans; Indazoles; Neoplasm Recurrence, Local; Pyrimidines; Salvage Therapy; Sarcoma, Ewing; Sulfonamides; Young Adult

2015
ABT-869 inhibits the proliferation of Ewing Sarcoma cells and suppresses platelet-derived growth factor receptor beta and c-KIT signaling pathways.
    Molecular cancer therapeutics, 2010, Volume: 9, Issue:3

    Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Cell Proliferation; Down-Regulation; Humans; Indazoles; Mice; Mice, Inbred NOD; Mice, SCID; Phenylurea Compounds; Proto-Oncogene Proteins c-kit; Receptor, Platelet-Derived Growth Factor beta; Sarcoma, Ewing; Signal Transduction; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2010
Initial testing of the multitargeted kinase inhibitor pazopanib by the Pediatric Preclinical Testing Program.
    Pediatric blood & cancer, 2012, Volume: 59, Issue:3

    Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Child; Child, Preschool; Female; Humans; Indazoles; Mice; Mice, SCID; Protein Kinase Inhibitors; Pyrimidines; Receptor, Platelet-Derived Growth Factor beta; Rhabdomyosarcoma; Sarcoma, Ewing; Sulfonamides; Vascular Endothelial Growth Factors; Xenograft Model Antitumor Assays

2012